8-K current report · filed Jun 3, 2026

Inhibrx Biosciences, Inc. (INBX) 8-K Current Report: June 3, 2026

Short answer

Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 79% quorum, with 11,541,232 of 14,607,286 shares represented at the meeting.

Inhibrx Biosciences, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • 79% quorum, with 11,541,232 of 14,607,286 shares represented at the meeting
  • Kimberly Manhard elected Class II director through 2029 with 9,035,097 votes for
  • Douglas G. Forsyth elected Class II director through 2029 with 7,608,469 votes for and 1,463,474 withheld
  • BDO USA, P.C. auditor appointment ratified with 11,510,478 votes for and 30,347 against

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Inhibrx Biosciences, Inc. 8-K filings

Get the next INBX 8-K as it lands

Follow INBX for push alerts, or ask the research agent what this filing means.